This document outlines vaccination programs for broilers, broiler breeders, and commercial layers. It provides the vaccine, age for administration, route of administration, and type for various diseases including Marek's disease, Newcastle disease, infectious bronchitis, infectious bursal disease, tenosynovitis, encephalomyelitis, fowlpox, chicken infectious anemia, laryngotracheitis, fowl cholera, and mycoplasma gallisepticum. Vaccines are administered via different routes such as spray, water, wing web, intraocular, or parenteral depending on the vaccine and age of the bird.
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOCX, PDF, TXT or read online on Scribd
0 ratings0% found this document useful (0 votes)
81 views
Vaccination Program For Poultry
This document outlines vaccination programs for broilers, broiler breeders, and commercial layers. It provides the vaccine, age for administration, route of administration, and type for various diseases including Marek's disease, Newcastle disease, infectious bronchitis, infectious bursal disease, tenosynovitis, encephalomyelitis, fowlpox, chicken infectious anemia, laryngotracheitis, fowl cholera, and mycoplasma gallisepticum. Vaccines are administered via different routes such as spray, water, wing web, intraocular, or parenteral depending on the vaccine and age of the bird.
16–18 wk Newcastle/infectious Water or aerosol B1 or LaSota/Mass
bronchitis
Every 60–90 days Newcastle/infectious Parenteral Inactivated
or 18 wk bronchitis
Vaccination Program for Commercial Layers
Age Vaccine Route Type
1 day Marek's disease SC Turkey herpesvirus and
SB-1
14 –21 days Newcastle/infectious Water B1/Mass
bronchitis
14–21 days Infectious bursal disease Water Intermediate
5 wk Newcastle/infectious Water or coarse B1/Mass
bronchitis spray
8–10 wk Newcastle/infectious Water or coarse B1 or LaSota/Mass
bronchitis spray
10–12 wk Encephalomyelitis Wing web Live, chick-embryo origin
10–12 wk Fowlpox Wing web Modified live
10–12 wk Laryngotracheitis Intraocular Modified live
10–14 wk Mycoplasma gallisepticumb Intraocular or spray Mild live strain
or 18 wk Parenteral Inactivated
12–14 wk Newcastle/infectious Water or aerosol B1 or LaSota/Mass
bronchitis
16–18 wk Newcastle/infectious Water or aerosol B1 or LaSota/Mass
bronchitis
Every 60–90 days Newcastle/infectious Parenteral Inactivated
or 18 wk bronchitis a This is an example of a vaccination program. Individual programs are highly variable and reflect local conditions, disease prevalence, severity of challenge, and individual preferences.